Skip to main content
Top
Published in: Diabetologia 3/2013

01-03-2013 | Article

Serum potassium is associated with prediabetes and newly diagnosed diabetes in hypertensive adults from the general population: The KORA F4-Study

Authors: C. Meisinger, D. Stöckl, I. M. Rückert, A. Döring, B. Thorand, M. Heier, C. Huth, P. Belcredi, B. Kowall, W. Rathmann

Published in: Diabetologia | Issue 3/2013

Login to get access

Abstract

Aims/hypothesis

Evidence suggests that low serum potassium concentrations or hypokalaemia induced by the intake of diuretics are associated with incident diabetes and increased risk for diabetes in persons with hypertension. We examined a possible association between serum potassium and prediabetes (defined as isolated impaired fasting glucose [i-IFG], isolated impaired glucose tolerance [i-IGT] or combined IFG/IGT), as well as known and newly diagnosed diabetes (NDD), in 32- to 81-year-old men and women with and without hypertension.

Methods

This cross-sectional analysis was based on 2,948 participants in the Cooperative Health Research in the Region of Augsburg (KORA) F4 study conducted in 2006–2008 in southern Germany. Serum concentrations of potassium were measured by indirect potentiometry.

Results

In the total sample there was no association between serum potassium concentrations and prediabetes. In hypertensive persons however serum potassium levels in the first and second quartile compared with the highest quartile were independently significantly associated with prediabetes after multivariable adjustment (OR for prediabetes, 2.02 [95% CI 1.27, 3.21] for quartile 2 and 2.00 [95% CI 1.27, 3.15] for quartile 1), while in persons without hypertension no association was found. In multinomial logistic regression analysis these findings could be confirmed. In hypertensive participants after multivariable adjustment the associations were statistically significant for i-IGT and NDD (i-IGT OR 1.23; NDD OR 1.41). However, in non-hypertensive persons, all associations between serum potassium levels and each of the categories of impaired glucose regulation were non-significant.

Conclusions/interpretation

Serum potassium levels were independently associated with prediabetes and NDD in hypertensive adults from the general population.
Literature
1.
go back to reference Herman WH, Zimmet P (2012) Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes Care 35:943–944PubMedCrossRef Herman WH, Zimmet P (2012) Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes Care 35:943–944PubMedCrossRef
2.
go back to reference Lee DC, Park I, Jun TW et al (2012) Physical activity and body mass index and their associations with the development of type 2 diabetes in Korean men. Am J Epidemiol 176:43–51PubMedCrossRef Lee DC, Park I, Jun TW et al (2012) Physical activity and body mass index and their associations with the development of type 2 diabetes in Korean men. Am J Epidemiol 176:43–51PubMedCrossRef
3.
go back to reference Rowe JW, Tobin JD, Rosa RM, Andres R (1980) Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 29:498–502PubMedCrossRef Rowe JW, Tobin JD, Rosa RM, Andres R (1980) Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 29:498–502PubMedCrossRef
4.
go back to reference Gorden P (1973) Glucose intolerance with hypokalemia. Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia. Diabetes 22:544–551PubMed Gorden P (1973) Glucose intolerance with hypokalemia. Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia. Diabetes 22:544–551PubMed
5.
go back to reference Shafi T, Appel LJ, Miller ER, Klag MJ, Parekh RS (2008) Changes in serum potassium mediate thiazide-induced diabetes. Hypertension 52:1022–1029PubMedCrossRef Shafi T, Appel LJ, Miller ER, Klag MJ, Parekh RS (2008) Changes in serum potassium mediate thiazide-induced diabetes. Hypertension 52:1022–1029PubMedCrossRef
6.
go back to reference Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL (2006) Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 48:219–224PubMedCrossRef Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL (2006) Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 48:219–224PubMedCrossRef
7.
go back to reference Chatterjee R, Yeh HC, Shafi T et al (2010) Serum and dietary potassium and risk of incident type 2 diabetes mellitus. Arch Intern Med 170(19):1745–1751PubMedCrossRef Chatterjee R, Yeh HC, Shafi T et al (2010) Serum and dietary potassium and risk of incident type 2 diabetes mellitus. Arch Intern Med 170(19):1745–1751PubMedCrossRef
8.
go back to reference Chatterjee R, Yeh HC, Shafi T et al (2011) Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 93:1087–1091PubMedCrossRef Chatterjee R, Yeh HC, Shafi T et al (2011) Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 93:1087–1091PubMedCrossRef
9.
go back to reference Heianza Y, Hara S, Arase Y et al (2011) Low serum potassium levels and risk of type 2 diabetes: the Toranomon Hospital Health Management Center Study 1 (TOPICS 1). Diabetologia 54:762–766PubMedCrossRef Heianza Y, Hara S, Arase Y et al (2011) Low serum potassium levels and risk of type 2 diabetes: the Toranomon Hospital Health Management Center Study 1 (TOPICS 1). Diabetologia 54:762–766PubMedCrossRef
10.
go back to reference Ferrannini E, Cushman WC (2012) Diabetes and hypertension: the bad companions. Lancet 380:601–610PubMedCrossRef Ferrannini E, Cushman WC (2012) Diabetes and hypertension: the bad companions. Lancet 380:601–610PubMedCrossRef
11.
go back to reference Rathmann W, Kowall B, Tamayo T et al (2010) Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study. Ann Med 44:170–177PubMedCrossRef Rathmann W, Kowall B, Tamayo T et al (2010) Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study. Ann Med 44:170–177PubMedCrossRef
12.
go back to reference Rathmann W, Haastert B, Icks A et al (2003) High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 46:182–189PubMed Rathmann W, Haastert B, Icks A et al (2003) High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 46:182–189PubMed
13.
go back to reference Meisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H (2002) Sex differences in risk factors for incident type 2 diabetes mellitus. The MONICA Augsburg Cohort Study. Arch Intern Med 162:82–89PubMedCrossRef Meisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H (2002) Sex differences in risk factors for incident type 2 diabetes mellitus. The MONICA Augsburg Cohort Study. Arch Intern Med 162:82–89PubMedCrossRef
14.
go back to reference International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes (2009). Diabetes Care 32:1327–1334 International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes (2009). Diabetes Care 32:1327–1334
15.
go back to reference Pun KK, Ho PW (1989) Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus. Diabetes Res Clin Pract 7:163–167PubMedCrossRef Pun KK, Ho PW (1989) Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus. Diabetes Res Clin Pract 7:163–167PubMedCrossRef
16.
go back to reference McNair P, Madsbad S, Christiansen C, Christensen MS, Transbol I (1982) Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients. Clin Chim Acta 120:243–250PubMedCrossRef McNair P, Madsbad S, Christiansen C, Christensen MS, Transbol I (1982) Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients. Clin Chim Acta 120:243–250PubMedCrossRef
17.
go back to reference Chatterjee R, Colangelo LA, Yeh HC et al (2012) Potassium intake and risk of incident type 2 diabetes mellitus: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetologia 55:1295–1303PubMedCrossRef Chatterjee R, Colangelo LA, Yeh HC et al (2012) Potassium intake and risk of incident type 2 diabetes mellitus: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetologia 55:1295–1303PubMedCrossRef
18.
go back to reference Langford HG, Cutter G, Oberman A, Kansal P, Russell G (1990) The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: results of a cross-sectional study in patients from the hypertension detection and followup program. J Hum Hypertens 4:491–500PubMed Langford HG, Cutter G, Oberman A, Kansal P, Russell G (1990) The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: results of a cross-sectional study in patients from the hypertension detection and followup program. J Hum Hypertens 4:491–500PubMed
19.
go back to reference Plavinik FL, Rodrigues CI, Zanella MT, Ribeiro AB (1992) Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 19(suppl II):II26–II29PubMedCrossRef Plavinik FL, Rodrigues CI, Zanella MT, Ribeiro AB (1992) Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 19(suppl II):II26–II29PubMedCrossRef
20.
go back to reference Kehayias JJ, Fiatarone MA, Zhuang H, Roubenoff R (1997) Total body potassium and body fat: relevance to aging. Am J Clin Nutr 66:904–910PubMed Kehayias JJ, Fiatarone MA, Zhuang H, Roubenoff R (1997) Total body potassium and body fat: relevance to aging. Am J Clin Nutr 66:904–910PubMed
21.
go back to reference He Q, Heo M, Heshka S et al (2003) Total body potassium differs by sex and race across the adult age span. Am J Clin Nutr 78:72–77PubMed He Q, Heo M, Heshka S et al (2003) Total body potassium differs by sex and race across the adult age span. Am J Clin Nutr 78:72–77PubMed
22.
go back to reference Linshaw MA (1987) Potassium homeostasis and hypokalemia. Pediatr Clin North Am 34:649–681PubMed Linshaw MA (1987) Potassium homeostasis and hypokalemia. Pediatr Clin North Am 34:649–681PubMed
24.
26.
go back to reference Sagild U, Andersen V, Andreasen PB (1961) Glucose tolerance and insulin responsiveness in experimental potassium depletion. Acta Med Scand 169:243–251PubMedCrossRef Sagild U, Andersen V, Andreasen PB (1961) Glucose tolerance and insulin responsiveness in experimental potassium depletion. Acta Med Scand 169:243–251PubMedCrossRef
27.
go back to reference Meisinger C, Strassburger K, Heier M et al (2010) Prevalence of undiagnosed diabetes and impaired glucose regulation in 35-59-year-old individuals in Southern Germany: the KORA F4 Study. Diabet Med 27:360–362PubMedCrossRef Meisinger C, Strassburger K, Heier M et al (2010) Prevalence of undiagnosed diabetes and impaired glucose regulation in 35-59-year-old individuals in Southern Germany: the KORA F4 Study. Diabet Med 27:360–362PubMedCrossRef
Metadata
Title
Serum potassium is associated with prediabetes and newly diagnosed diabetes in hypertensive adults from the general population: The KORA F4-Study
Authors
C. Meisinger
D. Stöckl
I. M. Rückert
A. Döring
B. Thorand
M. Heier
C. Huth
P. Belcredi
B. Kowall
W. Rathmann
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2786-8

Other articles of this Issue 3/2013

Diabetologia 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine